MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Harvard Bioscience Operating Cash Flow 2011-2026 | HBIO
Annual Operating Cash Flow Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.73 M | 1.44 M | 14 M | 1.15 M | 1.26 M | 9.33 M | 8.04 M | 2.88 M | 1.06 M | 5.38 M | 705 K | 4.35 M | 4.06 M | 8.06 M | 6.65 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14 M | 705 K | 5.01 M |
Quarterly Operating Cash Flow Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 2.99 M | - | - | - | 1.4 M | - | - | - | 1.81 M | - | - | - | -1.99 M | - | - | - | 1.04 M | - | 6.84 M | 5.24 M | 2.87 M | - | 5.82 M | 2.67 M | 2.01 M | - | 291 K | 1.72 M | 448 K | - | 2 M | -135 K | -610 K | - | 3.66 M | 216 K | -726 K | - | -1.06 M | -981 K | -497 K | - | 3.09 M | 2.49 M | 2.49 M | - | 2.81 M | - | 576 K | - | 6.66 M | 4.15 M | 1.6 M | - | 4 M | - | 1.14 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.84 M | -1.99 M | 1.94 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 10.97 | -2.14 % | $ 26.6 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 73.25 | -2.85 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
180 M | $ 116.64 | -3.61 % | $ 2.87 B | USA |
 |
The Cooper Companies
COO
|
796 M | $ 61.98 | -1.76 % | $ 12.3 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 2.08 | -1.19 % | $ 95.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.32 | -2.82 % | $ 26.3 M | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 122.49 | -2.35 % | $ 3.92 B | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 59.16 | -1.0 % | $ 2.98 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 6.26 | 1.79 % | $ 53.1 K | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.01 | -1.84 % | $ 185 M | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 21.04 | -3.62 % | $ 1.42 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 451.08 | -3.33 % | $ 161 B | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 116.64 | -2.55 % | $ 5.65 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 26.0 | -2.64 % | $ 1.29 B | USA |
 |
STERIS plc
STE
|
1.15 B | $ 212.66 | -3.39 % | $ 21 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.56 | 0.03 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 9.85 | -3.24 % | $ 203 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 64.8 | -2.91 % | $ 3.83 B | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 66.14 | -0.71 % | $ 214 M | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 295.56 | 1.22 % | $ 21.4 B | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 26.23 | -1.02 % | $ 4.41 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.47 | -2.67 % | $ 2.29 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.62 | -0.46 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 50.62 | -1.73 % | $ 166 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 110.54 | -1.65 % | $ 2.5 B | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 20.58 | -1.54 % | $ 948 M | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.79 | -4.29 % | $ 163 M | USA |
 |
Baxter International
BAX
|
845 M | $ 17.18 | -4.32 % | $ 8.81 B | USA |
 |
ResMed
RMD
|
351 M | $ 212.53 | -2.05 % | $ 31 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 27.5 | -3.44 % | $ 1.31 B | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 10.63 | -3.19 % | $ 434 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 145.61 | -2.6 % | $ 41.9 B | USA |
 |
Nephros
NEPH
|
827 K | $ 3.25 | -2.11 % | $ 33.8 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 2.97 | -1.33 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 113.92 | -2.99 % | $ 6.35 M | USA |